| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | | Sold All | -49,408 | -100 % | | | | -1.63 % | $1,482 | | | | | | News Article | History of Timber Hill Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 35,312 | Sold Some | -31,957 | -47.50 % | $66,387 | $63,915 | $-2,472 | -3.72 % | $2,237 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Avanir Pharmaceuticals |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 32,200 | Added More | 11,775 | 57.64 % | $60,536 | $58,282 | $-2,254 | -3.72 % | $-824 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 49,156 | No Change | 0 | 0 % | $93,888 | $88,972 | $-4,916 | -5.23 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 30,018 | New Holding | 30,018 | 100 % | $57,334 | $54,333 | $-3,002 | -5.23 % | $-3,002 | | | | | | News Article | History of Citadel L P Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 20,145 | New Holding | 20,145 | 100 % | $38,477 | $36,462 | $-2,015 | -5.23 % | $-2,015 | | | | | | News Article | History of Morgan Stanley Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 631,325 | Added More | 353,526 | 127.25 % | $1,205,831 | $1,142,698 | $-63,133 | -5.23 % | $-35,353 | | | | | | News Article | History of Northern Trust Corp Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | | Sold All | -1,800,000 | -100 % | | | | -5.23 % | $180,000 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 64,016 | Sold Some | -30,846 | -32.51 % | $122,271 | $115,869 | $-6,402 | -5.23 % | $3,085 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 4,626 | Added More | 3,376 | 270.08 % | $8,836 | $8,373 | $-463 | -5.23 % | $-338 | | | | | | News Article | History of Us Bancorp De Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 160,000 | New Holding | 160,000 | 100 % | $305,600 | $289,600 | $-16,000 | -5.23 % | $-16,000 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wexford Capital Llc | Institution | 11,400 | New Holding | 11,400 | 100 % | $21,774 | $20,634 | $-1,140 | -5.23 % | $-1,140 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Winslow Management Company Llc | Institution | 200,000 | New Holding | 200,000 | 100 % | $382,000 | $362,000 | $-20,000 | -5.23 % | $-20,000 | | | | | | News Article | History of Winslow Management Company Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 25 | No Change | 0 | 0 % | $47 | $45 | $-1 | -2.68 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 192,926 | Sold Some | -47,524 | -19.76 % | $358,842 | $349,196 | $-9,646 | -2.68 % | $2,376 | | | | | | News Article | History of Axa Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 318 | Sold Some | -158 | -33.19 % | $591 | $576 | $-16 | -2.68 % | $8 | | | | | | News Article | History of Barclays Plc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 20,107 | New Holding | 20,107 | 100 % | $37,399 | $36,394 | $-1,005 | -2.68 % | $-1,005 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 3,000 | Sold Some | -62,133 | -95.39 % | $5,580 | $5,430 | $-150 | -2.68 % | $3,107 | | | | | | News Article | History of Credit Agricole S A Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 87 | Sold Some | -22,213 | -99.60 % | $162 | $157 | $-4 | -2.68 % | $1,111 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 124,235 | Added More | 84,256 | 210.75 % | $231,077 | $224,865 | $-6,212 | -2.68 % | $-4,213 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 34,093 | Added More | 1,368 | 4.18 % | $63,413 | $61,708 | $-1,705 | -2.68 % | $-68 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 19,800 | Sold Some | -3,400 | -14.65 % | $36,828 | $35,838 | $-990 | -2.68 % | $170 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 9,802 | New Holding | 9,802 | 100 % | $18,232 | $17,742 | $-490 | -2.68 % | $-490 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 1,338,801 | Sold Some | -221,599 | -14.20 % | $2,490,170 | $2,423,230 | $-66,940 | -2.68 % | $11,080 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 33,406 | Added More | 8,267 | 32.88 % | $62,135 | $60,465 | $-1,670 | -2.68 % | $-413 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 1,087,509 | Added More | 69,800 | 6.85 % | $2,022,767 | $1,968,391 | $-54,375 | -2.68 % | $-3,490 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 2,921,746 | Added More | 312,065 | 11.95 % | $5,434,448 | $5,288,360 | $-146,087 | -2.68 % | $-15,603 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 600,000 | New Holding | 600,000 | 100 % | $1,116,000 | $1,086,000 | $-30,000 | -2.68 % | $-30,000 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 587 | Sold Some | -32,338 | -98.21 % | $1,092 | $1,062 | $-29 | -2.68 % | $1,617 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 56,848 | Added More | 5,042 | 9.73 % | $105,737 | $102,895 | $-2,842 | -2.68 % | $-252 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 2,119 | Added More | 139 | 7.02 % | $3,941 | $3,835 | $-106 | -2.68 % | $-7 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 2,721 | Added More | 1,091 | 66.93 % | $5,061 | $4,925 | $-136 | -2.68 % | $-55 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -2,328 | -100 % | | | | -2.68 % | $116 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Avanir Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 70,800 | New Holding | 70,800 | 100 % | $131,688 | $128,148 | $-3,540 | -2.68 % | $-3,540 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | 37,356 | New Holding | 37,356 | 100 % | $72,471 | $67,614 | $-4,856 | -6.70 % | $-4,856 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 2,745 | Sold Some | -72,442 | -96.34 % | $5,325 | $4,968 | $-357 | -6.70 % | $9,417 | | | | | | News Article | History of Ubs Ag Ownership Of Avanir Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | | Sold All | -99,319 | -100 % | | | | -1.09 % | $1,986 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Avanir Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 59,331 | No Change | 0 | 0 % | $108,576 | $107,389 | $-1,187 | -1.09 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Avanir Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 50 | New Holding | 50 | 100 % | $92 | $91 | $-1 | -1.09 % | $-1 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 182,059 | No Change | 0 | 0 % | $333,168 | $329,527 | $-3,641 | -1.09 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Avanir Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 393,489 | Added More | 1,380 | 0.35 % | $720,085 | $712,215 | $-7,870 | -1.09 % | $-28 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Avanir Pharmaceuticals |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 16,093 | Sold Some | -7,756 | -32.52 % | $29,933 | $29,128 | $-805 | -2.68 % | $388 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Avanir Pharmaceuticals |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 610,326 | Added More | 124,642 | 25.66 % | $1,141,310 | $1,104,690 | $-36,620 | -3.20 % | $-7,479 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Avanir Pharmaceuticals |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 25 | No Change | 0 | 0 % | $48 | $45 | $-3 | -6.21 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Avanir Pharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -3,420 | -100 % | | | | -11.70 % | $821 | | | | | | News Article | History of Blackrock Inc Ownership Of Avanir Pharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 192,160 | Added More | 37,346 | 24.12 % | $393,928 | $347,810 | $-46,118 | -11.70 % | $-8,963 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Avanir Pharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 199,809 | Sold Some | -14,180 | -6.62 % | $411,607 | $361,654 | $-49,952 | -12.13 % | $3,545 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Avanir Pharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | Iwamoto Kong And Co Inc | Institution | 125 | No Change | 0 | 0 % | $258 | $226 | $-31 | -12.13 % | $0 | | | | | | News Article | History of Iwamoto Kong And Co Inc Ownership Of Avanir Pharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | Orrstown Financial Services Inc | Institution | 75 | No Change | 0 | 0 % | $155 | $136 | $-19 | -12.13 % | $0 | | | | | | News Article | History of Orrstown Financial Services Inc Ownership Of Avanir Pharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 56,702 | Added More | 25,602 | 82.32 % | $116,806 | $102,631 | $-14,176 | -12.13 % | $-6,401 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Avanir Pharmaceuticals |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 74,069 | No Change | 0 | 0 % | $154,064 | $134,065 | $-19,999 | -12.98 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Avanir Pharmaceuticals |
| 2009-10-14 | 2009-09-30 | 13F-HR | Dorsey Wright Associates | Institution | 248 | New Holding | 248 | 100 % | $518 | $449 | $-69 | -13.39 % | $-69 | | | | | | News Article | History of Dorsey Wright Associates Ownership Of Avanir Pharmaceuticals |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 74,100 | No Change | 0 | 0 % | $170,430 | $134,121 | $-36,309 | -21.30 % | $0 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Avanir Pharmaceuticals |
| 2009-10-06 | 2009-09-30 | 13F-HR | Agran Libbie | Institution | 16,750 | No Change | 0 | 0 % | $35,678 | $30,318 | $-5,360 | -15.02 % | $0 | | | | | | News Article | History of Agran Libbie Ownership Of Avanir Pharmaceuticals |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 65,133 | New Holding | 65,133 | 100 % | $129,615 | $117,891 | $-11,724 | -9.04 % | $-11,724 | | | | | | News Article | History of Credit Agricole S A Ownership Of Avanir Pharmaceuticals |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 2,609,681 | Added More | 1,779,379 | 214.30 % | $5,767,395 | $4,723,523 | $-1,043,872 | -18.09 % | $-711,752 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Avanir Pharmaceuticals |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 20,425 | Added More | 25 | 0.12 % | $39,625 | $36,969 | $-2,655 | -6.70 % | $-3 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Avanir Pharmaceuticals |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |